Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk

@inproceedings{Sharma2009ThinkingBL,
  title={Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk},
  author={Rakesh Kumar Sharma and Vibhuti N Singh and Hanumanth K Reddy},
  booktitle={Vascular health and risk management},
  year={2009}
}
Several large statin trials and meta-analyses have demonstrated a reduction in low-density lipoprotein cholesterol (LDL-C) and cardiovascular morbidity and mortality. Some trials have also highlighted the significance of residual cardiovascular risk after treatment of LDL-C to target levels. This reflects the complex nature of residual cardiovascular risk. This residual risk is partially due to low HDL-C and high triglycerides (TG) despite achievement of LDL goals with statin therapy. The NCEP… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 22 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 57 references

High-density lipoprotein cholesterol and cardiovascular disease

  • DJ Gordon
  • Four prospective American studies. Circulation
  • 1989
Highly Influential
4 Excerpts

The effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3

  • AJ Taylor
  • Curr Med Res Opin
  • 2006
Highly Influential
3 Excerpts

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

  • C Baigent
  • Lancet
  • 2005
Highly Influential
3 Excerpts

Similar Papers

Loading similar papers…